Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Metastatic Pancreatic Adenocarcinoma
×
irinotecan sucrosofate
×
Clear all
Filters
3
NCT02826486
2024-08-28
COMBAT
BioLineRx, Ltd.
Phase 2
Completed
80 enrolled
13 charts